QuickView for PDE4B;jsessionid=16BA33D194091596FBEEAE45E78F7A6A;jsessionid=B5644001EAA305AC8BFA0690EA55A3F0;jsessionid=5444C80E562647D2B7F90BD3D5A6A723;jsessionid=CCCAFCF3720AE3DF0C1411708BEF2FE1;jsessionid=6BF9C18A70B719B709CD63C0038DE058;jsessionid=CC6AC2514A63D16A83321F213F393387;jsessionid=B890BB85BE351DF48C10DAA274DCB492 (gene)

1. Treatment with the selective PDE4B inhibitor A-33 or PDE4D inhibitor zatolmilast prevents sleep depr…
2. Selective PDE4B and PDE4D inhibitors produce distinct behavioral responses to ethanol and GABAergic …
3. Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains.
4. Selective Inhibition of PDE4B Reduces Methamphetamine Reinforcement in Two C57BL/6 Substrains.
5. MiR-124-3p targeting PDE4B attenuates LPS-induced ALI through the TLR4/NF-κB signaling pathway.

There were no clinical trials for PDE4B;jsessionid=16BA33D194091596FBEEAE45E78F7A6A;jsessionid=B5644001EAA305AC8BFA0690EA55A3F0;jsessionid=5444C80E562647D2B7F90BD3D5A6A723;jsessionid=CCCAFCF3720AE3DF0C1411708BEF2FE1;jsessionid=6BF9C18A70B719B709CD63C0038DE058;jsessionid=CC6AC2514A63D16A83321F213F393387;jsessionid=B890BB85BE351DF48C10DAA274DCB492